GILDER GAGNON HOWE & CO LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2018$3,123,000
+19.4%
83,391
+25.3%
0.03%
+6.2%
Q1 2018$2,616,000
+14433.3%
66,557
+6913.4%
0.03%
Q1 2016$18,000
-14.3%
9490.0%0.00%
Q4 2015$21,000
-98.2%
949
-98.1%
0.00%
-100.0%
Q3 2015$1,173,000
-39.1%
50,122
-25.4%
0.02%
-24.0%
Q2 2015$1,925,000
+24.4%
67,228
+12.2%
0.02%
+13.6%
Q1 2015$1,548,000
+41.0%
59,942
+1.3%
0.02%
+37.5%
Q4 2014$1,098,000
+401.4%
59,165
+319.3%
0.02%
+433.3%
Q3 2014$219,00014,1100.00%
Other shareholders
INTERSECT ENT INC shareholders Q2 2018
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders